Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitril™ (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD)

NCT00208741 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00208741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00208741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitril™ (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD)
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2002
Completion date
November 30, 2003
Enrollment
50
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder